Literature DB >> 29048620

DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).

Maria Nowacka-Zawisza1, Ewelina Wiśnik1.   

Abstract

Prostate cancer is the second most commonly diagnosed cancer in men in Poland after lung cancer and the third leading cause of cancer-related mortality after lung and colon cancer. The etiology of most cases of prostate cancer are not fully known, and therefore it is essential to search for the molecular basis of prostate cancer and markers for the early diagnosis of this type of cancer. Epigenetics deals with changes in gene expression that are not determined by changes in the DNA sequence. Epigenetic changes refer to changes in the structure of DNA, which are the result of DNA modification after replication and/or post-translational modification of proteins associated with DNA. In contrast to mutations, epigenetic changes are reversible and occur very rapidly. The major epigenetic mechanisms include DNA methylation, modification of histone proteins, chemical modification and chromatin remodeling changes in gene expression caused by microRNAs (miRNAs). Epigenetic changes play an important role in malignant transformation and can be specific to types of cancers including prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29048620     DOI: 10.3892/or.2017.5972

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  30 in total

1.  Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer.

Authors:  Mingyi Ju; Jingyi Fan; Yuanjiang Zou; Mingjie Yu; Longyang Jiang; Qian Wei; Jia Bi; Baohui Hu; Qiutong Guan; Xinyue Song; Mingyan Dong; Lin Wang; Lifeng Yu; Yan Wang; Hui Kang; Wei Xin; Lin Zhao
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

Review 2.  Targeting signaling pathways in prostate cancer: mechanisms and clinical trials.

Authors:  Yundong He; Weidong Xu; Yu-Tian Xiao; Haojie Huang; Di Gu; Shancheng Ren
Journal:  Signal Transduct Target Ther       Date:  2022-06-24

3.  SUV39H1-DNMT3A-mediated epigenetic regulation of Tim-3 and galectin-9 in the cervical cancer.

Authors:  Li Zhang; Sijuan Tian; Minyi Zhao; Ting Yang; Shimin Quan; Qing Yang; Lihua Song; Xiaofeng Yang
Journal:  Cancer Cell Int       Date:  2020-07-20       Impact factor: 5.722

4.  Hypermethylation of Corticotropin Releasing Hormone Receptor-2 Gene in Ulcerative Colitis Associated Colorectal Cancer.

Authors:  Masayoshi Kobayashi; Nagahide Matsubara; Yutaka Nakachi; Yasushi Okazaki; Motoi Uchino; Hiroki Ikeuchi; Jihyng Song; Kei Kimura; Michiko Yasuhara; Akihito Babaya; Tomoki Yamano; Masataka Ikeda; Hiroki Nishikawa; Ikuo Matsuda; Seiichi Hirota; Naohiro Tomita
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

Review 5.  Computational methods and next-generation sequencing approaches to analyze epigenetics data: Profiling of methods and applications.

Authors:  Itika Arora; Trygve O Tollefsbol
Journal:  Methods       Date:  2020-09-14       Impact factor: 3.608

6.  Co-Targeting Plk1 and DNMT3a in Advanced Prostate Cancer.

Authors:  Zhuangzhuang Zhang; Lijun Cheng; Qiongsi Zhang; Yifan Kong; Daheng He; Kunyu Li; Matthew Rea; Jianling Wang; Ruixin Wang; Jinghui Liu; Zhiguo Li; Chongli Yuan; Enze Liu; Yvonne N Fondufe-Mittendorf; Lang Li; Tao Han; Chi Wang; Xiaoqi Liu
Journal:  Adv Sci (Weinh)       Date:  2021-05-29       Impact factor: 17.521

Review 7.  Recent Advances in Prostate Cancer Treatment and Drug Discovery.

Authors:  Ekaterina Nevedomskaya; Simon J Baumgart; Bernard Haendler
Journal:  Int J Mol Sci       Date:  2018-05-04       Impact factor: 5.923

8.  Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.

Authors:  Wei Wu; Jessica L Klockow; Michael Zhang; Famyrah Lafortune; Edwin Chang; Linchun Jin; Yang Wu; Heike E Daldrup-Link
Journal:  Pharmacol Res       Date:  2021-07-21       Impact factor: 10.334

Review 9.  Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention.

Authors:  Simona Izzo; Valeria Naponelli; Saverio Bettuzzi
Journal:  Nutrients       Date:  2020-04-06       Impact factor: 5.717

10.  Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients.

Authors:  Jiarong Cai; Fei Yang; Xuelian Chen; He Huang; Bin Miao
Journal:  Pharmgenomics Pers Med       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.